Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Automatic framework for PD-L1 expression evaluation in Latino patients with non-small cell lung cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide
10.1002/ijc.35278 · 2025 · External reference
Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer
10.1056/nejmoa1504627 · 2015 · External reference
Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
2024 · External reference
Comparing deep learning and pathologist quantification of cell-level PD-L1 expression in non-small cell lung cancer whole-slide images
10.1038/s41598-024-57067-1 · 2024 · External reference
Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancer
10.1136/jclinpath-2019-205993 · 2020 · External reference
Oncology meets immunology: the cancer-immunity cycle
10.1016/j.immuni.2013.07.012 · 2013 · External reference
Interobserver reproducibility of PD-L1 biomarker in non-small cell lung cancer: a multi-institutional study by 27 pathologists
10.4132/jptm.2019.09.29 · 2019 · External reference
Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma
10.3390/cancers13174409 · 2021 · External reference
Deep semi supervised generative learning for automated tumor proportion scoring on NSCLC tissue needle biopsies
10.1038/s41598-018-35501-5 · 2018 · External reference
PD-L1 expression in advanced NSCLC: insights into risk stratification and treatment selection from a systematic literature review
10.1016/j.lungcan.2017.08.005 · 2017 · External reference
A new AI-assisted scoring system for PD-L1 expression in NSCLC
10.1016/j.cmpb.2022.106829 · 2022 · External reference
Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer
10.1111/his.14571 · 2022 · External reference
Programmed death ligand 1 (PD-L1) as a predictive biomarker for pembrolizumab therapy in patients with advanced non-small-cell lung cancer (NSCLC)
10.1007/s12325-019-01057-7 · 2019 · External reference
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
10.1038/modpathol.2016.117 · 2016 · External reference
Comparative performance of PD - L1 scoring by pathologists and AI algorithms
10.1111/his.15432 · 2025 · External reference
You only look once: unified, real-time object detection
2016 · External reference
YOLOv8: a novel object detection algorithm with enhanced performance and robustness
2024 · External reference
Unresolved reference
External reference
Deep residual learning for image recognition
2016 · External reference
BACH: grand challenge on breast cancer histology images
10.1016/j.media.2019.05.010 · 2019 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
A systematic analysis of performance measures for classification tasks
10.1016/j.ipm.2009.03.002 · 2009 · External reference
The Pascal visual object classes (VOC) challenge
10.1007/s11263-009-0275-4 · 2010 · External reference